Purple Biotech (PPBT) Interest Expenses (2014 - 2026)

Purple Biotech (PPBT) has 12 years of Interest Expenses data on file, last reported at $31000.0 in Q1 2026.

• On a quarterly basis, Interest Expenses fell 11.43% year-over-year to $31000.0 in Q1 2026; TTM through Mar 2026 was $192000.0, a 61.68% decrease from a year earlier, with the FY2025 full-year figure at $982000.0, up 103.31% from the prior year.
• Interest Expenses for Q1 2026 stood at $31000.0, down from $214000.0 in the prior quarter.
• Over the last five years, Interest Expenses for PPBT reached as high as $2.1 million in Q4 2023 and fell as low as -$69000.0 in Q4 2024.
• Historically, Interest Expenses has averaged $183058.8 across 5 years, with a median of $31000.0 in 2026.
• Across the five-year window, Interest Expenses soared 11705.56% in 2023 and slumped 341.67% in 2025, its largest moves.
• Year by year, Interest Expenses stood at -$18000.0 in 2022, then surged by 11705.56% to $2.1 million in 2023, then slumped by 103.3% to -$69000.0 in 2024, then jumped by 410.14% to $214000.0 in 2025, then slumped by 85.51% to $31000.0 in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $31000.0 in Q1 2026, $214000.0 in Q4 2025, and $5000.0 in Q3 2025.